TopBP1 contributes to the chemoresistance in non-small cell lung cancer through upregulation of p53. [electronic resource]
Producer: 20170508Description: 3053-3064 p. digitalISSN:- 1177-8881
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Carrier Proteins -- antagonists & inhibitors
- DNA-Binding Proteins -- antagonists & inhibitors
- Drug Resistance, Neoplasm -- drug effects
- Humans
- Lung Neoplasms -- drug therapy
- Nuclear Proteins -- antagonists & inhibitors
- Tumor Cells, Cultured
- Tumor Suppressor Protein p53 -- metabolism
- Up-Regulation -- drug effects
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.